Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia-Reference-Cited by-同舟云学术

Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia

Published:2010-12 Issue:12 Volume:34 Page:1647-1655
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Luetkens Tim,Schafhausen Phillipe,Uhlich Frederike,Stasche Tim,Akbulak Ruken,Bartels Britta M.,Hildebrandt York,Gontarewicz Arthur,Kobold Sebastian,Meyer Sabrina,Gordic Maja,Bartels Katrin,Lajmi Nesrine,Cao Yanran,Kröger Nicolaus,Bokemeyer Carsten,Brümmendorf Tim H.,Atanackovic Djordje

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference59 articles.

1. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

2. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O’Brien;N Engl J Med,2003

3. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia;Hughes;N Engl J Med,2003

4. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia;Kantarjian;N Engl J Med,2002

5. Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate;Jabbour;Leukemia,2006

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PRAME for acute myeloid leukemia therapy;Frontiers in Immunology;2024-03-26

2. Immunohistochemistry for PRAME in Dermatopathology;The American Journal of Dermatopathology;2023-11

3. PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions;Surgical Pathology Clinics;2021-06

4. Epitope Analysis of Murine and Chimeric Monoclonal Antibodies Recognizing the Cancer Testis Antigen PRAME;Doklady Biochemistry and Biophysics;2020-05

5. The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer;Cell Proliferation;2020-03